These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16917932)

  • 1. Genetic evidence for ubiquitin-specific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease.
    Li Y; Schrodi S; Rowland C; Tacey K; Catanese J; Grupe A
    Hum Mutat; 2006 Oct; 27(10):1017-23. PubMed ID: 16917932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association analysis of single-nucleotide polymorphisms of USP24 and USP40 with Parkinson's disease in the Han Chinese population.
    Zhao B; Song W; Chen YP; Huang R; Chen K; Cao B; Yang Y; Shang HF
    Eur Neurol; 2012; 68(3):181-4. PubMed ID: 22923019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin specific proteases USP24 and USP40 and ubiquitin thiolesterase UCHL1 polymorphisms have synergic effect on the risk of Parkinson's disease among Taiwanese.
    Wu YR; Chen CM; Chen YC; Chao CY; Ro LS; Fung HC; Hsiao YC; Hu FJ; Lee-Chen GJ
    Clin Chim Acta; 2010 Jul; 411(13-14):955-8. PubMed ID: 20302855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease.
    Oliveira SA; Li YJ; Noureddine MA; Zuchner S; Qin X; Pericak-Vance MA; Vance JM
    Am J Hum Genet; 2005 Aug; 77(2):252-64. PubMed ID: 15986317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-mapping and candidate gene investigation within the PARK10 locus.
    Haugarvoll K; Toft M; Skipper L; Heckman MG; Crook JE; Soto A; Ross OA; Hulihan MM; Kachergus JM; Sando SB; White LR; Lynch T; Gibson JM; Uitti RJ; Wszolek ZK; Aasly JO; Farrer MJ
    Eur J Hum Genet; 2009 Mar; 17(3):336-43. PubMed ID: 18854859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution whole-genome association study of Parkinson disease.
    Maraganore DM; de Andrade M; Lesnick TG; Strain KJ; Farrer MJ; Rocca WA; Pant PV; Frazer KA; Cox DR; Ballinger DG
    Am J Hum Genet; 2005 Nov; 77(5):685-93. PubMed ID: 16252231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population.
    Shahabi HN; Westberg L; Melke J; Håkansson A; Belin AC; Sydow O; Olson L; Holmberg B; Nissbrandt H
    J Neural Transm (Vienna); 2009 May; 116(5):567-73. PubMed ID: 19381774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.
    Martin ER; Scott WK; Nance MA; Watts RL; Hubble JP; Koller WC; Lyons K; Pahwa R; Stern MB; Colcher A; Hiner BC; Jankovic J; Ondo WG; Allen FH; Goetz CG; Small GW; Masterman D; Mastaglia F; Laing NG; Stajich JM; Ribble RC; Booze MW; Rogala A; Hauser MA; Zhang F; Gibson RA; Middleton LT; Roses AD; Haines JL; Scott BL; Pericak-Vance MA; Vance JM
    JAMA; 2001 Nov; 286(18):2245-50. PubMed ID: 11710889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study.
    DeStefano AL; Lew MF; Golbe LI; Mark MH; Lazzarini AM; Guttman M; Montgomery E; Waters CH; Singer C; Watts RL; Currie LJ; Wooten GF; Maher NE; Wilk JB; Sullivan KM; Slater KM; Saint-Hilaire MH; Feldman RG; Suchowersky O; Lafontaine AL; Labelle N; Growdon JH; Vieregge P; Pramstaller PP; Klein C; Hubble JP; Reider CR; Stacy M; MacDonald ME; Gusella JF; Myers RH
    Am J Hum Genet; 2002 May; 70(5):1089-95. PubMed ID: 11920285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
    Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22.
    Moses EK; Fitzpatrick E; Freed KA; Dyer TD; Forrest S; Elliott K; Johnson MP; Blangero J; Brennecke SP
    Mol Hum Reprod; 2006 Aug; 12(8):505-12. PubMed ID: 16809377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in GIGYF2 is not associated with Parkinson disease.
    Nichols WC; Kissell DK; Pankratz N; Pauciulo MW; Elsaesser VE; Clark KA; Halter CA; Rudolph A; Wojcieszek J; Pfeiffer RF; Foroud T;
    Neurology; 2009 Jun; 72(22):1886-92. PubMed ID: 19279319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.
    Oliveira SA; Scott WK; Nance MA; Watts RL; Hubble JP; Koller WC; Lyons KE; Pahwa R; Stern MB; Hiner BC; Jankovic J; Ondo WG; Allen FH; Scott BL; Goetz CG; Small GW; Mastaglia FL; Stajich JM; Zhang F; Booze MW; Reaves JA; Middleton LT; Haines JL; Pericak-Vance MA; Vance JM; Martin ER
    Arch Neurol; 2003 Jul; 60(7):975-80. PubMed ID: 12873854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease.
    Ozturk A; Desai PP; Minster RL; Dekosky ST; Kamboh MI
    Neurobiol Aging; 2005; 26(8):1161-5. PubMed ID: 15917099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
    Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ
    Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association study of synphilin-1 in idiopathic Parkinson's disease.
    Myhre R; Klungland H; Farrer MJ; Aasly JO
    BMC Med Genet; 2008 Mar; 9():19. PubMed ID: 18366718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for novel loci for late-onset Parkinson's disease in a genetic isolate from the Netherlands.
    Bertoli-Avella AM; Dekker MC; Aulchenko YS; Houwing-Duistermaat JJ; Simons E; Testers L; Pardo LM; Rademaker TA; Snijders PJ; van Swieten JC; Bonifati V; Heutink P; van Duijn CM; Oostra BA
    Hum Genet; 2006 Mar; 119(1-2):51-60. PubMed ID: 16369765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease.
    Noureddine MA; Qin XJ; Oliveira SA; Skelly TJ; van der Walt J; Hauser MA; Pericak-Vance MA; Vance JM; Li YJ
    Hum Genet; 2005 Jun; 117(1):27-33. PubMed ID: 15827745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants of ubiquitin-specific peptidase 24 play a crucial role in lung cancer malignancy.
    Wang YC; Wang SA; Chen PH; Hsu TI; Yang WB; Chuang YP; Su WC; Liaw HJ; Chang WC; Hung JJ
    Oncogene; 2016 Jul; 35(28):3669-80. PubMed ID: 26568301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.